SPC70
Aflibercept
Status:
AfskrifuðApplication date:
16.5.2013Application published:
15.6.2013Grant published:
15.5.2020
Max expiry date:
4.2.2028Medicine name:
ZaltrapMedicine for children:
No
Timeline
Today
16.5.2013Application
15.6.2013Publication
15.5.2020Registration
4.2.2028Expires
Marketing license
IS authorization number:
EU/1/12/814/001-003Date:
12.2.2013
Foreign authorization number:
EU/1/12/814Date:
1.2.2013
Owner
Name:
Aventis Pharma S.A.Address:
20, avenue Raymond Aron, Antony FR
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP1824504